Liu S, Su T, Xia X, Zhou Z
Nature. 2024; 637(8048):1261-1271.
PMID: 39663457
DOI: 10.1038/s41586-024-08324-w.
Seo Y, Baine S, Kempton A, Rogers O, Lewis S, Adegboye K
Mol Ther Methods Clin Dev. 2023; 28:284-299.
PMID: 36816759
PMC: 9929442.
DOI: 10.1016/j.omtm.2023.01.004.
McCourt J, Stearns-Reider K, Mamsa H, Kannan P, Afsharinia M, Shu C
Skelet Muscle. 2023; 13(1):1.
PMID: 36609344
PMC: 9817407.
DOI: 10.1186/s13395-022-00311-x.
Bruge C, Geoffroy M, Benabides M, Pellier E, Gicquel E, Dhiab J
Biomedicines. 2022; 10(6).
PMID: 35740450
PMC: 9220148.
DOI: 10.3390/biomedicines10061428.
Yonekawa T, Rauckhorst A, El-Hattab S, Cuellar M, Venzke D, Anderson M
Sci Adv. 2022; 8(21):eabn0379.
PMID: 35613260
PMC: 9132445.
DOI: 10.1126/sciadv.abn0379.
Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
Mamsa H, Stark R, Shin K, Beedle A, Crosbie R
Hum Mol Genet. 2021; 31(5):718-732.
PMID: 34581784
PMC: 8895749.
DOI: 10.1093/hmg/ddab276.
Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus.
Herrador A, Fedeli C, Radulovic E, Campbell K, Moreno H, Gerold G
mBio. 2019; 10(2).
PMID: 30914516
PMC: 6437060.
DOI: 10.1128/mBio.02869-18.
Molecular Therapies for Muscular Dystrophies.
Lin A, Wang L
Curr Treat Options Neurol. 2018; 20(7):27.
PMID: 29926204
DOI: 10.1007/s11940-018-0509-2.
Nanospan, an alternatively spliced isoform of sarcospan, localizes to the sarcoplasmic reticulum in skeletal muscle and is absent in limb girdle muscular dystrophy 2F.
Peter A, Miller G, Capote J, DiFranco M, Solares-Perez A, Wang E
Skelet Muscle. 2017; 7(1):11.
PMID: 28587652
PMC: 5461684.
DOI: 10.1186/s13395-017-0127-9.
SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.
Bouyon S, Roussel V, Fromes Y
Hum Gene Ther. 2014; 25(8):694-704.
PMID: 24645914
PMC: 4137356.
DOI: 10.1089/hum.2013.132.
The costamere bridges sarcomeres to the sarcolemma in striated muscle.
Peter A, Cheng H, Ross R, Knowlton K, Chen J
Prog Pediatr Cardiol. 2013; 31(2):83-88.
PMID: 24039381
PMC: 3770312.
DOI: 10.1016/j.ppedcard.2011.02.003.
Identification of new dystroglycan complexes in skeletal muscle.
Johnson E, Li B, Yoon J, Flanigan K, Martin P, Ervasti J
PLoS One. 2013; 8(8):e73224.
PMID: 23951345
PMC: 3738564.
DOI: 10.1371/journal.pone.0073224.
Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.
Marshall J, Holmberg J, Chou E, Ocampo A, Oh J, Lee J
J Cell Biol. 2012; 197(7):1009-27.
PMID: 22734004
PMC: 3384411.
DOI: 10.1083/jcb.201110032.
Progress in gene therapy of dystrophic heart disease.
Lai Y, Duan D
Gene Ther. 2012; 19(6):678-85.
PMID: 22318092
PMC: 3628728.
DOI: 10.1038/gt.2012.10.
δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.
Blain A, Straub V
Skelet Muscle. 2011; 1(1):13.
PMID: 21798091
PMC: 3156636.
DOI: 10.1186/2044-5040-1-13.
Gait disturbances in dystrophic hamsters.
Hampton T, Kale A, Amende I, Tang W, McCue S, Bhagavan H
J Biomed Biotechnol. 2011; 2011:235354.
PMID: 21318074
PMC: 3035808.
DOI: 10.1155/2011/235354.
Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters.
Hoshijima M, Hayashi T, Jeon Y, Fu Z, Gu Y, Dalton N
Circ Heart Fail. 2010; 4(1):89-97.
PMID: 21036890
PMC: 3742303.
DOI: 10.1161/CIRCHEARTFAILURE.110.957258.
Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle.
Barton E
J Biol Chem. 2010; 285(22):17263-70.
PMID: 20371873
PMC: 2878052.
DOI: 10.1074/jbc.M109.063990.
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments.
Vitiello C, Faraso S, Sorrentino N, Di Salvo G, Nusco E, Nigro G
PLoS One. 2009; 4(3):e5051.
PMID: 19333401
PMC: 2660610.
DOI: 10.1371/journal.pone.0005051.
Structural and functional analysis of the sarcoglycan-sarcospan subcomplex.
Miller G, Wang E, Nassar K, Peter A, Crosbie R
Exp Cell Res. 2007; 313(4):639-51.
PMID: 17223103
PMC: 3855351.
DOI: 10.1016/j.yexcr.2006.11.021.